Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Dan G. Blazer III

Dr. Dan G. Blazer III

Surgical Oncologist

Dr. Dan G. Blazer III is a surgical oncologist with expertise in treating peritoneal mesothelioma at the Duke Cancer Center in Durham, North Carolina.

Get in touch
Jump to a Topic:

About Dan G. Blazer III

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

  • Team Leader icon

    Team Leader

  • 10+ Years of Experience icon

    10+ Years of Experience

  • Board Certified icon

    Board Certified in Medical Oncology

Get to Know Dr. Dan G. Blazer III

Surgical oncologist Dr. Dan G. Blazer III specializes in the combination treatment of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, known as HIPEC, that has proven so effective in treating patients with peritoneal mesothelioma.

Blazer, an associate professor of surgery, directs the Complex General Surgical Oncology and Hepatopancreatobiliary fellowship programs at the Duke University School of Medicine.

He joined Duke University in 2008, following in the footsteps of his father, a staff psychiatrist for almost 40 years. Blazer specializes in the surgical management of gastrointestinal malignancies, which includes advanced-stage colorectal, pancreatic and gastric cancers.

His cancer cases are heard before a multidisciplinary tumor board, ensuring all treatment options are considered.

Blazer’s expertise in the HIPEC procedure, which is done only in specialized treatment centers around the country, has helped extend survival dramatically for those with peritoneal malignancies.

Outside the clinic, he focuses on translational research, working to develop a more personalized approach to treatment.

Specialties of Dr. Dan G. Blazer III

  • Gastrointestinal malignancies

  • Peritoneal mesothelioma


  • Cytoreductive surgery

  • Whipple surgery

  • Multimodality approach to treatment

Dr. Dan G. Blazer III’s Experience and Medical Education

  • Duke Cancer Center

  • MD Anderson Cancer Center, National Cancer Institute (Fellowships)

  • University of Michigan Medical Center (Residency)

  • Duke University School of Medicine (M.D.)

Dr. Dan G. Blazer III’s Awards and Certifications

  • American Board of Surgery (General surgery)

  • Surgical Fellowship Awards

See More Top Mesothelioma Doctors

Publications of Dr. Dan G. Blazer III

  • Lazarides, A. et al. (2020, July 21). Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high‐grade soft tissue sarcomas of the extremities. Journal of Surgical Oncology.

  • Schmitz, R. et al. (2020, July 1). ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas. Annals of Surgical Oncology.

  • Moris, D. et al. (2018, February). Neuroendocrine Neoplasms of the Appendix: A Review of the Literature. Anticancer Research.

Disclaimer: Dr. Dan G. Blazer III has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Duke Health. (n.d.). Dan G. Blazer III, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 15, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now